IMV Inc. (IMVIF)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 7.67 Million USD | 140.51% |
| 2021 | -18.93 Million USD | 33.09% |
| 2020 | -28.3 Million CAD | -754.04% |
| 2019 | -3.31 Million CAD | 15.36% |
| 2018 | -3.91 Million USD | 41.41% |
| 2017 | -6.68 Million USD | -21.11% |
| 2016 | -5.51 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 Q3 | 7.02 Million USD | 598.96% |
| 2022 FY | 7.67 Million USD | 140.51% |
| 2022 Q2 | -1.4 Million USD | 83.86% |
| 2022 Q4 | 7.67 Million USD | 9.24% |
| 2022 Q1 | -8.71 Million USD | 53.96% |
| 2021 Q3 | -28.21 Million USD | 0.0% |
| 2021 Q4 | -18.93 Million USD | 32.89% |
| 2021 FY | -18.93 Million USD | 33.09% |
| 2020 FY | -28.3 Million CAD | -754.04% |
| 2019 FY | -3.31 Million CAD | 15.36% |
| 2018 FY | -3.91 Million USD | 41.41% |
| 2017 FY | -6.68 Million USD | -21.11% |
| 2016 FY | -5.51 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 585635.954% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -35.801% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 82.075% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 3172.879% |
| Rebus Holdings, Inc. | 305 Thousand USD | -2414.925% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 221.667% |
| Qrons Inc. | 351.42 Thousand USD | -2082.678% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -1132.481% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 82.34% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 37685.854% |
| Skye Bioscience, Inc. | -5.72 Million USD | 234.067% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 51.338% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -86.267% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -1808.807% |
| SQZ Biotechnologies Company | -36.23 Million USD | 121.167% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -242.093% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -727.29% |
| Mesoblast Limited | 55.85 Million USD | 86.268% |
| Marizyme, Inc. | 18.56 Million USD | 58.692% |
| Genus plc | 190.6 Million USD | 95.976% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -243.072% |
| Pharming Group N.V. | 109.8 Million USD | 93.014% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -791.671% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -531.897% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -1028.018% |
| ContraFect Corporation | -6.02 Million USD | 227.29% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -5597.102% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -563.868% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -39.416% |
| MultiCell Technologies, Inc. | 90.04 USD | -8518914.882% |
| ONE Bio Corp. | 9.04 Million USD | 15.149% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 1145.061% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 40.75% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -460.722% |
| Q BioMed Inc. | 4.06 Million USD | -88.929% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 74.895% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -661.179% |
| Biomind Labs Inc. | 711.4 Thousand USD | -978.226% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 87.331% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -283.643% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 40.105% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -2032.418% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -5386.625% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -38509.357% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -248.346% |
| GB Sciences, Inc. | 1.74 Million USD | -338.989% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 4273.57% |
| HST Global, Inc. | 96.79 Thousand USD | -7824.665% |
| CSL Limited | 10.52 Billion USD | 99.927% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -3619.636% |
| Halberd Corporation | 144.72 Thousand USD | -5200.213% |
| Enzolytics Inc. | 981.65 Thousand USD | -681.386% |
| Agentix Corp. | 37.63 Thousand USD | -20283.516% |
| Resverlogix Corp. | 6.45 Million USD | -18.904% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 1239.6% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.378% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 116.316% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -8.479% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -183.19% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 186.771% |
| AVAX Technologies, Inc. | -5.9 Million USD | 229.938% |
| Zenith Capital Corp. | 10.06 Thousand USD | -76117.419% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.723% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -3726.994% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -221.476% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -4562.676% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 41974.228% |
| Kadimastem Ltd | -253.1 Thousand USD | 3130.605% |
| Helix BioMedix, Inc. | -2.57 Million USD | 398.46% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 62.169% |
| BioStem Technologies, Inc. | 4.47 Million USD | -71.523% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -3711.363% |
| LadRx Corporation | -2.03 Million USD | 476.658% |
| Cell Source, Inc. | 9.23 Million USD | 16.914% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1107.638% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1107.638% |
| NovAccess Global Inc. | 2.17 Million USD | -252.107% |
| Affymax, Inc. | -5.59 Million USD | 237.047% |
| Itoco Inc. | 228.3 Thousand USD | -3259.769% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -5540.545% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -54.741% |
| Mobile Lads Corp. | 484.23 Thousand USD | -1484.059% |
| CytoDyn Inc. | 20.26 Million USD | 62.143% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 1185651.932% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 82860.462% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 0.46% |
| SYBLEU INC | 473.71 Thousand USD | -1519.23% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -72.1% |
| International Stem Cell Corporation | 2.59 Million USD | -196.159% |
| Bioxytran, Inc. | 1.89 Million USD | -303.943% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -12189.941% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -251.714% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -123.37% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 10.318% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -892.81% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 713.642% |
| Neutra Corp. | 52.18 Thousand USD | -14598.145% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 408.177% |
| PureTech Health plc | -167.19 Million USD | 104.588% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 3232.001% |
| IXICO plc | -4.44 Million USD | 272.581% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 41.974% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 86.016% |
| CSL Limited | 10.52 Billion USD | 99.927% |
| Cellectis S.A. | -43.81 Million USD | 117.505% |